Idaho Tech Begins Clinical Trials for FilmArray Blood Culture ID Panel | GenomeWeb

Idaho Technology said this week that it has initiated a clinical trial to evaluate its FilmArray Blood Culture Identification, or BCID, panel, which is designed to identify more than two dozen sepsis-causing organisms, as well as detect the presence of certain antibiotic resistance genes.

The clinical study is being conducted at several hospital-based clinical laboratories in the US, Idaho Tech said. The company expects the trial to run through the end of this year, and expects to submit a 510(k) application to the US Food and Drug Administration in early 2013.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.